Astrazeneca Share News (AZN)
AZN Share
AZN Share
AZN Share
AZN Share
AZN
AZN Share
AZN Level 2
AZN Live
AZN Broker
AZN Directors
AZN Financial
AZN
AZN Short
AZN
Last checked at -
(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)* M&S surges on first-half profit beat and FY outlook hike* Broadcaster ITV jumps on strong outlook for ad revenue* Halfords rises after upgr...
Read more
LONDON BROKER RATINGS: Four banks positive on Oxford Nanopore
Read more* News comes after review of vaccine operations* COVID-19 shot has suffered setbacks during pandemic* Company has antibody therapy proven to prevent infection* Move shows company sees future for COVID-19 vaccine beyond pandemic - analyst (Adds deta...
Read more* News comes after review of vaccine operations* COVID-19 shot has suffered setbacks during pandemic* Company has antibody therapy proven to prevent infection (Adds details and bullet points)By Pushkala AripakaNov 9 (Reuters) - AstraZeneca is creati...
Read more* News comes after review of vaccine operations* COVID-19 shot has suffered setbacks during pandemic* Company has antibody therapy proven to prevent infection* Move shows company sees future for COVID-19 vaccine beyond pandemic - analyst (Adds new ...
Read more(Adds detail, background)Nov 9 (Reuters) - AstraZeneca is creating a separate division for vaccines and antibody therapies to be led by senior executive Iskra Reic, the drugmaker said on Tuesday, as it builds focus on its COVID-19 shot and develop...
Read moreBy Ludwig BurgerNov 5 (Reuters) - GlaxoSmithKline said its anaemia pill for patients with kidney disease was shown to have about the same side effect risk as the current standard treatment in two important patient groups, a key advantage in a tigh...
Read moreUK earnings, trading statements calendar - next 7 days
Read more* STOXX 600 marks fifth week of gains* Pfizer COVID-19 pill turbo-charges travel stocks* Allegro surges after Mall Group deal* German, French stocks scale new peaks (Adds comments, updates prices throughout)By Shreyashi SanyalNov 5 (Reuters) - Europ...
Read more(Adds background on booster shots)By Pushkala Aripaka and Ludwig BurgerNov 4 (Reuters) - The European Union's drug regulator said on Thursday it was in discussions with AstraZeneca over possible authorisation of booster doses of the drugmaker's CO...
Read moreNov 4 (Reuters) - The European Union's drug regulator said on Thursday it was in discussions with AstraZeneca over possible authorisation of booster doses of the drugmaker's COVID-19 vaccine, after it already gave the green light to mRNA booster ...
Read moreLONDON MARKET CLOSE: Stocks fall as markets prepare for Fed meeting
Read more(Adds details on U.S. status, EU purchases and priorities)By Pushkala Aripaka and Ludwig BurgerNov 2 (Reuters) - Eli Lilly has retracted a request for European Union approval of its antibody-based treatment for COVID-19, citing a lack of demand fro...
Read moreBy Sangmi ChaSEOUL, Nov 2 (Reuters) - South Korea's private sector plans to invest 6.3 trillion won ($5.4 billion) in vaccine production and distribution by 2024, as the country seeks to become a global vaccine powerhouse, Prime Minister Kim Boo-k...
Read moreTOP NEWS: Astra transfers drug rights to Covis in USD270 million deal
Read more
Last checked at